What is Bio-Techne's revenue?

Written by Editorial Team | Last Updated: August 2026

Bio-Techne Corporation reports significant annual revenues reflecting its position as a global leader in life sciences tools and clinical diagnostics. As a publicly traded company, it discloses these figures in its annual and quarterly financial filings, which show revenue in the range of hundreds of millions to over a billion US dollars, consistent with its sustained history of organic growth and strategic acquisition. These revenue streams are diversified across multiple segments, including its research reagents portfolio, protein analysis instrumentation, and clinical diagnostics manufacturing businesses. Because revenue figures fluctuate based on global market demand for research tools, currency exchange rates, and the integration of new business acquisitions, stakeholders are encouraged to consult the company’s most recent Investor Relations reports and annual 10-K filings, which provide a precise, audited breakdown of financial performance and growth trends across their international operational footprint.

Related FAQs

Biotech jobs can be highly competitive, particularly for top-tier research or specialized engineering roles at prestigious firms.

A career in biotechnology can be demanding and, at times, inherently stressful due to the high-stakes environment in which professionals operate.

Determining the "best" biotechnology course depends heavily on your professional goals—whether you aim for research, manufacturing, regulatory affairs, or computational biology.

Bio-Techne Corporation employs several thousand highly skilled professionals across its global operations, which include manufacturing sites, research facilities, and commercial sales offices.

Minneapolis and the broader Twin Cities metropolitan area constitute a significant, internationally recognized hub for medical technology and biotechnology innovation.

Bio-Techne Corporation, originally founded as Techne Corporation in 1976, has a history rooted in the evolution of modern molecular biology and the demand for high-quality research tools.

Biotechnology and genetic engineering are closely related but represent different concepts in the scientific field.

The amount of math in biotechnology varies significantly depending on your role.

Biotechnology carries significant risks that require careful ethical and regulatory oversight.

Bio-Techne Corporation is a publicly traded company, listed on the Nasdaq stock exchange under the ticker symbol TECH.

Biotechnology is broadly categorized into four primary sectors, represented by different colors: Red, Green, White, and Blue.

Biotechnology is generally considered a high-paying field, particularly when compared to average national salary benchmarks in many developed nations.

Finding a job in the biotechnology sector is challenging but highly achievable for candidates who possess the right combination of specialized education, practical laboratory skills, and persistent networking.

Comparing the difficulty of biotechnology and engineering is inherently subjective, as both fields are intellectually demanding but require different types of cognitive approaches.

Bio-Techne is generally perceived as a strong, stable employer within the life sciences sector, known for offering a professional work environment, competitive compensation, and a clear alignment with the mission of advancing scientific discovery.

Kim Kelderman serves as the Chief Executive Officer of Bio-Techne Corporation. Taking on this leadership role, he is responsible for overseeing the company's long-term strategic vision, global operations, and financial performance.

Bio-Techne Corporation is a premier manufacturer of high-quality life science research tools, reagents, and clinical diagnostic products.

The biotechnology sector is well-known for offering highly competitive compensation packages, especially for roles that require specialized technical education, such as Ph.D. holders, molecular biologists, data scientists, and process engineers.

The timeline to become a professional in the biotechnology field varies by the specific role.

Biotechnology encompasses a wide range of applications that improve human health and sustainability.

Bio-Techne Corporation is headquartered in Minneapolis, Minnesota, in the United States. This central location serves as the hub for the company’s executive leadership, strategic operations, and financial administration.

No, biotech jobs are not broadly declining; in fact, the sector has demonstrated remarkable resilience and long-term secular growth driven by advances in medicine, aging global demographics, and the digital transformation of biological research.

Bio-Techne’s company values are centered on driving scientific discovery through innovation, integrity, and customer-centricity.

Salaries in the biotechnology field are highly variable and depend on factors such as educational level, specific job function, geographic location, and company size.

Bio-Techne provides an extensive and highly sophisticated catalog of research products that serve as foundational tools for life science laboratories worldwide.